Immune Checkpoint Agents and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Immune Checkpoint Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Checkpoint Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Checkpoint Agents Overall Market Size
2.1 Global Immune Checkpoint Agents Market Size: 2022 VS 2031
2.2 Global Immune Checkpoint Agents Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Immune Checkpoint Agents Sales: 2019-2031
3 Company Landscape
3.1 Top Immune Checkpoint Agents Players in Global Market
3.2 Top Global Immune Checkpoint Agents Companies Ranked by Revenue
3.3 Global Immune Checkpoint Agents Revenue by Companies
3.4 Global Immune Checkpoint Agents Sales by Companies
3.5 Global Immune Checkpoint Agents Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Immune Checkpoint Agents Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immune Checkpoint Agents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Checkpoint Agents Players in Global Market
3.8.1 List of Global Tier 1 Immune Checkpoint Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune Checkpoint Agents Market Size Markets, 2022 & 2031
4.1.2 Anti-PD-L1 Drug
4.1.3 Anti-PD-1 Drug
4.1.4 CTLA4
4.2 By Type - Global Immune Checkpoint Agents Revenue & Forecasts
4.2.1 By Type - Global Immune Checkpoint Agents Revenue, 2019-2024
4.2.2 By Type - Global Immune Checkpoint Agents Revenue, 2024-2031
4.2.3 By Type - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
4.3 By Type - Global Immune Checkpoint Agents Sales & Forecasts
4.3.1 By Type - Global Immune Checkpoint Agents Sales, 2019-2024
4.3.2 By Type - Global Immune Checkpoint Agents Sales, 2024-2031
4.3.3 By Type - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
4.4 By Type - Global Immune Checkpoint Agents Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Checkpoint Agents Market Size, 2022 & 2031
5.1.2 Lung Cancer
5.1.3 Colorectal Cancer
5.1.4 BreastCancer
5.1.5 Prostate Cancer
5.1.6 Melanoma
5.1.7 Blood Cancers
5.2 By Application - Global Immune Checkpoint Agents Revenue & Forecasts
5.2.1 By Application - Global Immune Checkpoint Agents Revenue, 2019-2024
5.2.2 By Application - Global Immune Checkpoint Agents Revenue, 2024-2031
5.2.3 By Application - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
5.3 By Application - Global Immune Checkpoint Agents Sales & Forecasts
5.3.1 By Application - Global Immune Checkpoint Agents Sales, 2019-2024
5.3.2 By Application - Global Immune Checkpoint Agents Sales, 2024-2031
5.3.3 By Application - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
5.4 By Application - Global Immune Checkpoint Agents Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Immune Checkpoint Agents Market Size, 2022 & 2031
6.2 By Region - Global Immune Checkpoint Agents Revenue & Forecasts
6.2.1 By Region - Global Immune Checkpoint Agents Revenue, 2019-2024
6.2.2 By Region - Global Immune Checkpoint Agents Revenue, 2024-2031
6.2.3 By Region - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
6.3 By Region - Global Immune Checkpoint Agents Sales & Forecasts
6.3.1 By Region - Global Immune Checkpoint Agents Sales, 2019-2024
6.3.2 By Region - Global Immune Checkpoint Agents Sales, 2024-2031
6.3.3 By Region - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Immune Checkpoint Agents Revenue, 2019-2031
6.4.2 By Country - North America Immune Checkpoint Agents Sales, 2019-2031
6.4.3 US Immune Checkpoint Agents Market Size, 2019-2031
6.4.4 Canada Immune Checkpoint Agents Market Size, 2019-2031
6.4.5 Mexico Immune Checkpoint Agents Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Immune Checkpoint Agents Revenue, 2019-2031
6.5.2 By Country - Europe Immune Checkpoint Agents Sales, 2019-2031
6.5.3 Germany Immune Checkpoint Agents Market Size, 2019-2031
6.5.4 France Immune Checkpoint Agents Market Size, 2019-2031
6.5.5 U.K. Immune Checkpoint Agents Market Size, 2019-2031
6.5.6 Italy Immune Checkpoint Agents Market Size, 2019-2031
6.5.7 Russia Immune Checkpoint Agents Market Size, 2019-2031
6.5.8 Nordic Countries Immune Checkpoint Agents Market Size, 2019-2031
6.5.9 Benelux Immune Checkpoint Agents Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Immune Checkpoint Agents Revenue, 2019-2031
6.6.2 By Region - Asia Immune Checkpoint Agents Sales, 2019-2031
6.6.3 China Immune Checkpoint Agents Market Size, 2019-2031
6.6.4 Japan Immune Checkpoint Agents Market Size, 2019-2031
6.6.5 South Korea Immune Checkpoint Agents Market Size, 2019-2031
6.6.6 Southeast Asia Immune Checkpoint Agents Market Size, 2019-2031
6.6.7 India Immune Checkpoint Agents Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Immune Checkpoint Agents Revenue, 2019-2031
6.7.2 By Country - South America Immune Checkpoint Agents Sales, 2019-2031
6.7.3 Brazil Immune Checkpoint Agents Market Size, 2019-2031
6.7.4 Argentina Immune Checkpoint Agents Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immune Checkpoint Agents Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Immune Checkpoint Agents Sales, 2019-2031
6.8.3 Turkey Immune Checkpoint Agents Market Size, 2019-2031
6.8.4 Israel Immune Checkpoint Agents Market Size, 2019-2031
6.8.5 Saudi Arabia Immune Checkpoint Agents Market Size, 2019-2031
6.8.6 UAE Immune Checkpoint Agents Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Immune Checkpoint Agents Major Product Offerings
7.1.4 Bristol Myers Squibb Immune Checkpoint Agents Sales and Revenue in Global (2019-2024)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Immune Checkpoint Agents Major Product Offerings
7.2.4 Merck Immune Checkpoint Agents Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Immune Checkpoint Agents Major Product Offerings
7.3.4 AstraZeneca Immune Checkpoint Agents Sales and Revenue in Global (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Immune Checkpoint Agents Major Product Offerings
7.4.4 Roche Immune Checkpoint Agents Sales and Revenue in Global (2019-2024)
7.4.5 Roche Key News & Latest Developments
8 Global Immune Checkpoint Agents Production Capacity, Analysis
8.1 Global Immune Checkpoint Agents Production Capacity, 2019-2031
8.2 Immune Checkpoint Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Checkpoint Agents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immune Checkpoint Agents Supply Chain Analysis
10.1 Immune Checkpoint Agents Industry Value Chain
10.2 Immune Checkpoint Agents Upstream Market
10.3 Immune Checkpoint Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Checkpoint Agents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Immune Checkpoint Agents in Global Market
Table 2. Top Immune Checkpoint Agents Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Immune Checkpoint Agents Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Immune Checkpoint Agents Revenue Share by Companies, 2019-2024
Table 5. Global Immune Checkpoint Agents Sales by Companies, (K Units), 2019-2024
Table 6. Global Immune Checkpoint Agents Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Immune Checkpoint Agents Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Immune Checkpoint Agents Product Type
Table 9. List of Global Tier 1 Immune Checkpoint Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Immune Checkpoint Agents Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Immune Checkpoint Agents Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Immune Checkpoint Agents Sales (K Units), 2019-2024
Table 15. By Type - Global Immune Checkpoint Agents Sales (K Units), 2024-2031
Table 16. By Application ? Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Immune Checkpoint Agents Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Immune Checkpoint Agents Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Immune Checkpoint Agents Sales (K Units), 2019-2024
Table 20. By Application - Global Immune Checkpoint Agents Sales (K Units), 2024-2031
Table 21. By Region ? Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Immune Checkpoint Agents Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Immune Checkpoint Agents Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Immune Checkpoint Agents Sales (K Units), 2019-2024
Table 25. By Region - Global Immune Checkpoint Agents Sales (K Units), 2024-2031
Table 26. By Country - North America Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Immune Checkpoint Agents Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Immune Checkpoint Agents Sales, (K Units), 2019-2024
Table 29. By Country - North America Immune Checkpoint Agents Sales, (K Units), 2024-2031
Table 30. By Country - Europe Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Immune Checkpoint Agents Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Immune Checkpoint Agents Sales, (K Units), 2019-2024
Table 33. By Country - Europe Immune Checkpoint Agents Sales, (K Units), 2024-2031
Table 34. By Region - Asia Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Immune Checkpoint Agents Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Immune Checkpoint Agents Sales, (K Units), 2019-2024
Table 37. By Region - Asia Immune Checkpoint Agents Sales, (K Units), 2024-2031
Table 38. By Country - South America Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Immune Checkpoint Agents Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Immune Checkpoint Agents Sales, (K Units), 2019-2024
Table 41. By Country - South America Immune Checkpoint Agents Sales, (K Units), 2024-2031
Table 42. By Country - Middle East & Africa Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Immune Checkpoint Agents Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Immune Checkpoint Agents Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Immune Checkpoint Agents Sales, (K Units), 2024-2031
Table 46. Bristol Myers Squibb Company Summary
Table 47. Bristol Myers Squibb Immune Checkpoint Agents Product Offerings
Table 48. Bristol Myers Squibb Immune Checkpoint Agents Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Bristol Myers Squibb Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Immune Checkpoint Agents Product Offerings
Table 52. Merck Immune Checkpoint Agents Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Merck Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Immune Checkpoint Agents Product Offerings
Table 56. AstraZeneca Immune Checkpoint Agents Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Immune Checkpoint Agents Product Offerings
Table 60. Roche Immune Checkpoint Agents Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Roche Key News & Latest Developments
Table 62. Immune Checkpoint Agents Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 63. Global Immune Checkpoint Agents Capacity Market Share of Key Manufacturers, 2021-2024
Table 64. Global Immune Checkpoint Agents Production by Region, 2019-2024 (K Units)
Table 65. Global Immune Checkpoint Agents Production by Region, 2024-2031 (K Units)
Table 66. Immune Checkpoint Agents Market Opportunities & Trends in Global Market
Table 67. Immune Checkpoint Agents Market Drivers in Global Market
Table 68. Immune Checkpoint Agents Market Restraints in Global Market
Table 69. Immune Checkpoint Agents Raw Materials
Table 70. Immune Checkpoint Agents Raw Materials Suppliers in Global Market
Table 71. Typical Immune Checkpoint Agents Downstream
Table 72. Immune Checkpoint Agents Downstream Clients in Global Market
Table 73. Immune Checkpoint Agents Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Immune Checkpoint Agents Segment by Type in 2022
Figure 2. Immune Checkpoint Agents Segment by Application in 2022
Figure 3. Global Immune Checkpoint Agents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Checkpoint Agents Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Immune Checkpoint Agents Revenue, 2019-2031 (US$, Mn)
Figure 7. Immune Checkpoint Agents Sales in Global Market: 2019-2031 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Immune Checkpoint Agents Revenue in 2022
Figure 9. By Type - Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 11. By Type - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 12. By Type - Global Immune Checkpoint Agents Price (USD/Unit), 2019-2031
Figure 13. By Application - Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 15. By Application - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 16. By Application - Global Immune Checkpoint Agents Price (USD/Unit), 2019-2031
Figure 17. By Region - Global Immune Checkpoint Agents Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Immune Checkpoint Agents Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 20. By Region - Global Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 21. By Country - North America Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 22. By Country - North America Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 23. US Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 28. Germany Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 29. France Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 37. China Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 41. India Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 43. By Country - South America Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 44. Brazil Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Immune Checkpoint Agents Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Immune Checkpoint Agents Sales Market Share, 2019-2031
Figure 48. Turkey Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Immune Checkpoint Agents Revenue, (US$, Mn), 2019-2031
Figure 52. Global Immune Checkpoint Agents Production Capacity (K Units), 2019-2031
Figure 53. The Percentage of Production Immune Checkpoint Agents by Region, 2022 VS 2031
Figure 54. Immune Checkpoint Agents Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
